Datametrex AI Limited (CVE:DM - Get Free Report) traded down 16.7% on Thursday . The stock traded as low as C$0.10 and last traded at C$0.13. 269,138 shares changed hands during trading, an increase of 659% from the average session volume of 35,479 shares. The stock had previously closed at C$0.15.
Datametrex AI Stock Down 7.7 %
The stock has a fifty day moving average price of C$0.01 and a 200 day moving average price of C$0.01. The company has a debt-to-equity ratio of 554.49, a current ratio of 0.40 and a quick ratio of 2.44. The stock has a market capitalization of C$72.48 million, a P/E ratio of -1.71 and a beta of 2.59.
Datametrex AI Company Profile
(
Get Free Report)
Datametrex AI Limited engages in the collecting, analyzing, and presenting structured and unstructured data using machine learning and artificial intelligence in Canada and South Korea. The company operates through two segments, AI and Technology and Health Care. It offers health security businesses, including concierge medical services, and telemedicine services; Imagine Health consisting of integrated medical centre, pharmacy, and ancillary services; physician consultation and medical professional services; and sale of prescription drugs and over-the-counter products.
Featured Articles
Before you consider Datametrex AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Datametrex AI wasn't on the list.
While Datametrex AI currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.